+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Facial Injectables Market Research Report by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4995152
  • Report
  • July 2021
  • Region: Global
  • 191 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Facial Injectables Market will Grow to USD 19.95 Billion by 2026, at a CAGR of 11.44%

FEATURED COMPANIES

  • Advanced Dermatology
  • Antares Pharma
  • Eisai Co. Ltd
  • Ipse
  • Mylan N. V.
  • Pfizer Inc
The Global Facial Injectables Market size was estimated at USD 10.41 Billion in 2020 and expected to reach USD 11.56 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 11.44% to reach USD 19.95 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Facial Injectables to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Facial Injectables Market was studied across Anti-aging Injections and Dermal Fillers. The Anti-aging Injections is further studied across Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Micro Particles. The Dermal Fillers is further studied across Collagen Fillers, Hyaluronic Acid, and Synthetic Fillers.
  • Based on End User, the Facial Injectables Market was studied across Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes, and Hospitals.
  • Based on Region, the Facial Injectables Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Facial Injectables Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Facial Injectables Market, including Advanced Dermatology, Allergan, Plc, Anika Therapeutics, Inc., Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Bloomage BioTechnology Corporation Limited, ColBar LifeScience Ltd., Eisai Co. Ltd, Eli Lilly and Company,, F. Hoffmann-La Roche AG,, Galderma Laboratories, L.P., Inovio Pharmaceuticals Inc., Ipse, Johnson and Johnson Services Inc., Medytox, Inc., Merz, Inc., Mylan N. V., Novartis AG, Novo Nordisk, Pfizer Inc, Prollenium Medical Technologies Inc., Sanofi, Sanofi Biosurgery Inc., Sinclair Pharma, Suneva Medical, Inc., Teva Pharmaceutical Industries Ltd, and Valeant Pharmaceuticals North America LLC..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Facial Injectables Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Facial Injectables Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Facial Injectables Market?
4. What is the competitive strategic window for opportunities in the Global Facial Injectables Market?
5. What are the technology trends and regulatory frameworks in the Global Facial Injectables Market?
6. What is the market share of the leading vendors in the Global Facial Injectables Market?
7. What modes and strategic moves are considered suitable for entering the Global Facial Injectables Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Advanced Dermatology
  • Antares Pharma
  • Eisai Co. Ltd
  • Ipse
  • Mylan N. V.
  • Pfizer Inc
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. End User Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing focus on physical appearance among consumers globally
5.1.1.2. Rising penchant toward minimally invasive procedures among people
5.1.1.3. Growing disposable income among people and availability of numerous treatment options
5.1.2. Restraints
5.1.2.1. Relatively high costs of the fillers
5.1.3. Opportunities
5.1.3.1. Introduction of advanced treatment options
5.1.3.2. Rising adoption of self-injectable devices and the growing geriatric population
5.1.4. Challenges
5.1.4.1. Strict regulatory concerns and probable side effects such as rashes
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Facial Injectables Market, by Type
6.1. Introduction
6.2. Anti-aging Injections
6.2.1. Botulinum Toxin A
6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
6.3. Dermal Fillers
6.3.1. Collagen Fillers
6.3.2. Hyaluronic Acid
6.3.3. Synthetic Fillers

7. Facial Injectables Market, by End User
7.1. Introduction
7.2. Beauty Clinics
7.3. Dermatology Clinics
7.4. Dermatology Research Institutes
7.5. Hospitals

8. Americas Facial Injectables Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Facial Injectables Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Facial Injectables Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Advanced Dermatology
12.2. Allergan, Plc
12.3. Anika Therapeutics, Inc.
12.4. Antares Pharma
12.5. AstraZeneca
12.6. Becton, Dickinson and Company
12.7. Bloomage BioTechnology Corporation Limited
12.8. ColBar LifeScience Ltd.
12.9. Eisai Co. Ltd
12.10. Eli Lilly and Company,
12.11. F. Hoffmann-La Roche AG,
12.12. Galderma Laboratories, L.P.
12.13. Inovio Pharmaceuticals Inc.
12.14. Ipse
12.15. Johnson and Johnson Services Inc.
12.16. Medytox, Inc.
12.17. Merz, Inc.
12.18. Mylan N. V.
12.19. Novartis AG
12.20. Novo Nordisk
12.21. Pfizer Inc
12.22. Prollenium Medical Technologies Inc.
12.23. Sanofi
12.24. Sanofi Biosurgery Inc.
12.25. Sinclair Pharma
12.26. Suneva Medical, Inc.
12.27. Teva Pharmaceutical Industries Ltd
12.28. Valeant Pharmaceuticals North America LLC.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2020 (USD BILLION)
FIGURE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 6. GLOBAL FACIAL INJECTABLES MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL FACIAL INJECTABLES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2026
FIGURE 11. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, 2018-2026 (USD BILLION)
FIGURE 22. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 23. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, 2018-2026 (USD BILLION)
FIGURE 24. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 25. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 26. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2026
FIGURE 28. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. AMERICAS FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 37. ARGENTINA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 38. BRAZIL FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. CANADA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. MEXICO FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. UNITED STATES FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. CHINA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. INDIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. INDONESIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. JAPAN FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. MALAYSIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. SINGAPORE FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. THAILAND FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. FRANCE FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. GERMANY FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. ITALY FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. QATAR FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. RUSSIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. SPAIN FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. GLOBAL FACIAL INJECTABLES MARKET: FPNV POSITIONING MATRIX
FIGURE 66. GLOBAL FACIAL INJECTABLES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL FACIAL INJECTABLES MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL FACIAL INJECTABLES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. AMERICAS FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 18. ARGENTINA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. BRAZIL FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. CANADA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. MEXICO FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. UNITED STATES FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. ASIA-PACIFIC FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. AUSTRALIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. CHINA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. INDIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. INDONESIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. JAPAN FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. MALAYSIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. PHILIPPINES FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. SINGAPORE FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. SOUTH KOREA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. THAILAND FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. FRANCE FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. GERMANY FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. ITALY FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. NETHERLANDS FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. QATAR FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. RUSSIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. SAUDI ARABIA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. SOUTH AFRICA FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. SPAIN FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. UNITED ARAB EMIRATES FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. UNITED KINGDOM FACIAL INJECTABLES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. GLOBAL FACIAL INJECTABLES MARKET: SCORES
TABLE 47. GLOBAL FACIAL INJECTABLES MARKET: BUSINESS STRATEGY
TABLE 48. GLOBAL FACIAL INJECTABLES MARKET: PRODUCT SATISFACTION
TABLE 49. GLOBAL FACIAL INJECTABLES MARKET: RANKING
TABLE 50. GLOBAL FACIAL INJECTABLES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 51. GLOBAL FACIAL INJECTABLES MARKET: MERGER & ACQUISITION
TABLE 52. GLOBAL FACIAL INJECTABLES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 53. GLOBAL FACIAL INJECTABLES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 54. GLOBAL FACIAL INJECTABLES MARKET: INVESTMENT & FUNDING
TABLE 55. GLOBAL FACIAL INJECTABLES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 56. GLOBAL FACIAL INJECTABLES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Advanced Dermatology
  • Allergan, Plc
  • Anika Therapeutics, Inc.
  • Antares Pharma
  • AstraZeneca
  • Becton, Dickinson and Company
  • Bloomage BioTechnology Corporation Limited
  • ColBar LifeScience Ltd.
  • Eisai Co. Ltd
  • Eli Lilly and Company,
  • F. Hoffmann-La Roche AG,
  • Galderma Laboratories, L.P.
  • Inovio Pharmaceuticals Inc.
  • Ipse
  • Johnson and Johnson Services Inc.
  • Medytox, Inc.
  • Merz, Inc.
  • Mylan N. V.
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc
  • Prollenium Medical Technologies Inc.
  • Sanofi
  • Sanofi Biosurgery Inc.
  • Sinclair Pharma
  • Suneva Medical, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Valeant Pharmaceuticals North America LLC.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll